Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 198 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Type 2 Diabetes Self-Management Clear all

Conditions: Type 2 Diabetes
Interventions: Acceptance and Commitment Therapy, Abbott FreeStyle® Libre® 3, Generic Education; Behavioral · Device · Other
Lead sponsor: Sam Houston State University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Conroe, Texas

Conditions: Diabetes Mellitus, Type 2, PreDiabetes
Interventions: iCan Diabetes Self-management and Prevention Support Group; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes Mellitus, Type 1
Interventions: Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 12 Years to 35 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 23
States / cities: Orange, California • Palo Alto, California • San Francisco, California + 20 more

Conditions: Prediabetes
Interventions: National Diabetes Prevention Program (DPP), Sleep Health Digital Application, Time-Restricted Eating (TRE); Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Diabetes Mellitus, Type 2
Interventions: OneTouch® Ultra®2 System, Standard care; Behavioral
Lead sponsor: LifeScan; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 10
States / cities: Phoenix, Arizona • San Diego, California • Wilmington, Delaware + 7 more

Conditions: Type 2 Diabetes (Adult Onset), Medication Adherence
Interventions: REACH-Es, ETAU; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Diabetes Mellitus, Type 2
Interventions: Meal replacement system, Intensive lifestyle Intervention; Dietary Supplement · Behavioral
Lead sponsor: Loma Linda University; Other
Eligibility: 25 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: Mobile and connected health; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Houston, Texas

Conditions: Type 2 Diabetes Mellitus
Interventions: Taking on Diabetes to Advance You (TODAY) Project; Behavioral
Lead sponsor: Arlene Schmid; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Type 2 Diabetes Mellitus
Interventions: Virtual Diabetes Self-Care and Education Program, Fitbit, Smartphone; Behavioral · Device
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 21 Years to 80 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Edinburg, Texas

Conditions: Type 1 Diabetes
Interventions: Closed loop, Home glucose monitoring, Insulin pump, Continuous glucose monitor; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 6 Years to 45 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 5
States / cities: Stanford, California • Aurora, Colorado • New Haven, Connecticut + 2 more

Conditions: Type 1 Diabetes
Interventions: FAM intervention consisting of a Follower of glucose data, Action Plan, and Remote Monitoring of glucose data, standard of care; Device · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Food Insecurity, Diabetes Mellitus, Type 2
Interventions: Type 2 Diabetes Appropriate Food Boxes + Diabetes Education; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Disfrutando; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Columbia, Missouri • Kansas City, Missouri

Conditions: Type 2 Diabetes
Interventions: Online Diabetes Self-Management Education and Support (DSMES) Program, Standard of Care; Behavioral
Lead sponsor: Omada Health, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Mateo, California

Conditions: Type 2 Diabetes
Interventions: Diabetes Self-Management Education and Support (DSMES) Videos, Community Health Worker Support (CHW); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Type 2
Interventions: Albiglutide, Insulin Glargine and Insulin Lispro; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 814 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 39
States / cities: Searcy, Arkansas • Huntington Beach, California • Long Beach, California + 34 more

Conditions: Overweight, Obese
Interventions: Decrease Energy Density of the Diet, Increase Steps per Day, Consumption of Self-made Meals; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 35 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Diabetes
Interventions: Continuous Glucose Monitoring and Education Support; Other
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Diabetes Mellitus, Type 2
Interventions: Remote Patient Monitoring; Device
Lead sponsor: Tracy Jalbuena MD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Rockport, Maine

Conditions: Treatment, Diabetes
Interventions: Medication Adherence Program (MAP); Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin glargine, 300U/mL, Insulin degludec, 100 U/mL, Non-insulin anti-diabetic treatment; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 929 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 74
States / cities: Sheffield, Alabama • Phoenix, Arizona • Anaheim, California + 62 more

Conditions: Obesity, Cardiovascular Risk Factor
Interventions: Outreach Support for Weight Loss Goal Setting and Self-Weighing, Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions, Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes
Interventions: Blood glucose meter, Eversense CGM System; Device
Lead sponsor: Senseonics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 925 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 23
States / cities: Los Angeles, California • Englewood, Colorado • Hamden, Connecticut + 20 more

Search by objective public record fields.

ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

iCan Diabetes Self-management and Prevention Program

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Nested Pilot Study Comparing Two Treatments to Reduce Type 2 Diabetes Risk in At-Risk Delawareans

Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes

REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

Weight Management for the Remission of Type 2 Diabetes Using a Proprietary Meal Replacement System- Diabetes Remission Study (DRS)

Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care

Taking on Diabetes to Advance You (TODAY)

Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

FAM (Follower, Action Plan, and Remote Monitoring) Intervention to Reduce Severe Hyperglycemia in Adults With Type 1 Diabetes Mellitus at Risk for Diabetic Ketoacidosis

Delivering Health: Addressing Diabetes and Food Insecurity

Effectiveness of and Implementation Strategies for 'Disfrutando'.

Evaluation of a Digital Diabetes Self-Management Education and Support Program

Implementing an Effective Diabetes Intervention Among Low-Income Immigrants

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Foundations for Health

Continuous Glucose Monitoring and Diabetes

Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals With Type 2 Diabetes

The Medication Adherence Program

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Coordinating Pragmatic Primary Care Population Management for Obesity

Eversense® Non-adjunctive Use Post Approval Study